Factors Associated with Medication Adherence Among Patients with Severe Mental Disorders in China: A Propensity Score Matching Study

References

• China DCAP. Standards for management and treatment of severe mental disorders (2018 edition). Available from: http://www.gov.cn/gongbao/content/2018/content_5338247.htm. Accessed May 20, 2020.
   Google Scholar
• Xinhua News Agency. The number of patients with severe mental disorders registered in China reached 5.81 million. Available from: http://www.xinhuanet.com/2018-01/26/c_1122323778.htm. Accessed August 12, 2019.
   Google Scholar
• Liu NH, Daumit GL, Dua T, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017;16(1):30. doi:10.1002/wps.20384
   PubMed Web of Science ®Google Scholar
• Chen Z. Survey on psychological status and family burden of family members of hospitalized patients with schizophrenia. J Qilu Nurs. 2010;11.
   Google Scholar
• Guo CY, Jun LÜ, Wu MF, Wei XH. Management of registered patients with severe mental illness in Jinshan District, Shanghai. Chin J Rehabil Theory Pract. 2018;24(06):734–739.
   Google Scholar
• WHO. Guidelines for the Management of Physical Health Conditions in Adults with Severe Mental Disorders. Geneva: World Health Organization; 2018.
   Google Scholar
• Stentzel U, Berg NVD, Schulze LN, et al. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry. 2018;18(1):155. doi:10.1186/s12888-018-1737-4
   PubMed Web of Science ®Google Scholar
• Weiden P, Glazer W. Assessment and treatment selection for “revolving door” inpatients with schizophrenia. Psychiatry Quart. 1997;68(4):377–392. doi:10.1023/A:1025499131905
   Web of Science ®Google Scholar
• Hogarty GE, Goldberg SC, Schooler NR. Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients. Arch Gen Psychiatry. 1974;31(5):609–618. doi:10.1001/archpsyc.1974.01760170011002
   Web of Science ®Google Scholar
• Loebel A, Lieberman J, Alvir J, Geisler J, Koreen A, Chakos M. Time to treatment response in successive episodes of early onset schizophrenia. Schizophr Res. 1995;15(1–2):158. doi:10.1016/0920-9964(95)95489-V
   Web of Science ®Google Scholar
• Peter H, Cecilia B, Jan S. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43.
   Google Scholar
• Jónsdóttir H, Opjordsmoen S, Birkenaes AB, et al. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. J Clin Psychopharm. 2010;30(2):169–175. doi:10.1097/JCP.0b013e3181d2191e
   PubMed Web of Science ®Google Scholar
• Kampman O, Lehtinen K. Compliance in psychoses. Acta Psychiat Scand. 1999;100(3):167–175. doi:10.1111/j.1600-0447.1999.tb10842.x
   Web of Science ®Google Scholar
• Ravi L, Jan S. Treatment non-adherence in affective disorders. Acta Psychiat Scand. 2010;105(3):164–172.
   Google Scholar
• Law MR, Soumerai SB, Dennis RD, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiat. 2008;69(1):47. doi:10.4088/JCP.v69n0107
   PubMed Web of Science ®Google Scholar
• Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiat Scand. 2002;106(4):286–290. doi:10.1034/j.1600-0447.2002.02437.x
   PubMed Web of Science ®Google Scholar
• Veltman A, Cameron JI, Stewart DE. The experience of providing care to relatives with chronic mental illness. J Nerv Ment Dis. 2002;190(2):108–114. doi:10.1097/00005053-200202000-00008
   PubMed Web of Science ®Google Scholar
• Tham XC, Xie H, Chng CM, Seah XY, Lopez V, Klainin-Yobas P. Factors affecting medication adherence among adults with schizophrenia: a literature review. Arch Psychiatr Nurs. 2016;30(6):797–809. doi:10.1016/j.apnu.2016.07.007
   PubMed Web of Science ®Google Scholar
• Abdelbaki A, Ouelletplamondon C, Malla A. Pharmacotherapy challenges in patients with first-episode psychosis. J Affect Disorders. 2012;138(138 Suppl):S3–S14. doi:10.1016/j.jad.2012.02.029
   Web of Science ®Google Scholar
• Sweileh WM, Ihbesheh MS, Jarar IS, et al. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia. Curr Clin Pharmacol. 2012;7(1):49–55. doi:10.2174/157488412799218761
   PubMedGoogle Scholar
• Moritz S, Favrod J, Andreou C, et al. Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophrenia Bull. 2013;39(4):917–922. doi:10.1093/schbul/sbs005
   PubMed Web of Science ®Google Scholar
• Tadele E, Amha T, Dagim A, Gebremedhin S, Adissu A. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PLoS One. 2015;10(3):e120560.
   Web of Science ®Google Scholar
• Mullins CD, Obeidat NA, Cuffel BJ, Naradzay J, Loebel AD. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. Schizophr Res. 2008;98(1):8–15. doi:10.1016/j.schres.2007.04.035
   Web of Science ®Google Scholar
• Mccann TV, Lu S. Medication adherence and significant others’ support of consumers with schizophrenia in Australia. Nurs Health Sci. 2009;11(3):228–234. doi:10.1111/j.1442-2018.2009.00440.x
   Web of Science ®Google Scholar
• Yang J, Ko YH, Paik JW, et al. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res. 2012;134(2–3):226–231. doi:10.1016/j.schres.2011.11.008
   PubMed Web of Science ®Google Scholar
• Rungruangsiripan M, Sitthimongkol Y, Maneesriwongul W, Talley S, Vorapongsathorn T. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia. Arch Psychiat Nurs. 2011;25(4):269–283. doi:10.1016/j.apnu.2010.09.002
   Web of Science ®Google Scholar
• Zhou Q-H. Clinical investigation and analysis of drug compliance in patients with severe mental disorders in community. Health Must-Read Magazine. 2018;(6):290–291.
   Google Scholar
• Yang Q-H, Yun Xiao, Zheng KE, Ya-lan Liao. Effect of knowledge and behavioral level of caregivers on medication compliance in patients with severe mental disorders. J Guangdong Med Univ. 2018;36(5):581–584.
   Google Scholar
• Li Y-L. Study on the effect of management network of patients with severe mental disorders on medication compliance and recurrence rate. Electron J Clin Med Lit. 2019;6(31):81–82.
   Google Scholar
• Cheng X, Yang J-Y, Li D-D, Zhu H-J, Tong Y-B. Relationship between medication compliance and quality of life in patients with schizophrenia. Guangdong Med J. 2019;40(1):116–119.
   Google Scholar
• Xu J, Wang J, Wimo A, Qiu C. The economic burden of mental disorders in China, 2005–2013: implications for health policy. BMC Psychiatry. 2016;16:137. doi:10.1186/s12888-016-0839-0
   PubMed Web of Science ®Google Scholar
• Good BJ, Good MJ. Significance of the 686 program for China and for global mental health. Shanghai Arch Psychiatry. 2012;24(3):175.
   PubMedGoogle Scholar
• Jupiter DC. Propensity score matching: retrospective randomization? J Foot Ankle Surg. 2017;56(2):417–420. doi:10.1053/j.jfas.2017.01.013
   PubMed Web of Science ®Google Scholar
• Morgan CJ. Reducing bias using propensity score matching. J Nucl Cardiol. 2017;s12317–s12350.
   Web of Science ®Google Scholar
• Li Q-T, Song J-W, Zhang W-J, et al. Free medication for severe mental illness in rural communities management. Chin J Health Psychol. 2014;22(10):1494–1496.
   Google Scholar
• Yang Q-P, Zhang H. The influence of free medication in community on compliance and relapse of schizophrenia. J Clin Psychiatry. 2011;21(6):404–405.
   Google Scholar
• Marc DH, Correll CU, Julio B, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.
   Web of Science ®Google Scholar
• Zhao J-W, Xu Y-H, Pan J-X, et al. The evaluation of free medication policy for psychotic patients in poverty in Shanghai Jiading district. Shanghai Arch Psychiatry. 2006;6:342–343.
   Google Scholar
• Qiao Y-S, Zhao S-Q, Cui W. The effect of mental health education diverse family therapy on social and family functioning in patients with schizophrenia. Chin J Health Psychol. 2019;27(2):165–169.
   Google Scholar
• Ye Z-J, Zhou X, Liang L-P. Effects of health education on family members on self-awareness and medication compliance of patients with mental illness. Chin J Rural Med Pharm. 2018;25(2):61–62.
   Google Scholar
• Han S-F, Li S-F, Li L, Huang J-R, Jiang L, Liu X. Cause analysis and health education of schizophrenia patients stopping drug. Chin J Health Psychol. 2011;19(5):529–530.
   Google Scholar
• Taj F, Tanwir M, Aly Z, et al. Factors associated with non-adherence among psychiatric patients at a tertiary care hospital, Karachi, Pakistan: a questionnaire based cross-sectional study. J Pak Med Assoc. 2008;58(8):432–436.
   PubMedGoogle Scholar
• Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatr. 2012;2(5):74. doi:10.5498/wjp.v2.i5.74
   PubMedGoogle Scholar
• Farley JF, Hansen RA, Yuisenberg KS, Maciejewski ML. Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions. Prim Care Companion CNS Disord. 2012;14(3).
   PubMedGoogle Scholar
• Margeti BA, Jakovljevi M, Ivanec D, Toi G, Margeti B. Novelty seeking and medication adherence in patients with schizophrenia. Psychiat Res. 2011;186(1):143.
   Web of Science ®Google Scholar
• Maeda K, Kasai K, Watanabe A, Henomatsu K, Rogers MA, Kato N. Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia. Psychiat Serv. 2006;57(8):1203–1205. doi:10.1176/ps.2006.57.8.1203
   PubMed Web of Science ®Google Scholar
• Johnson F, Ozdemir SR, Hauber A, Burch S, Thompson T. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. Med Care. 2007;45(6):545–552. doi:10.1097/MLR.0b013e318040ad90
   PubMed Web of Science ®Google Scholar
• Linden M, Scheel TF. Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride. J Psychopharmacol. 2006;20(6):815–823. doi:10.1177/0269881106061154
   Web of Science ®Google Scholar
• Xiao L, Xie YF. Influencing factors for medication adherence of patients with schizophrenia to paliperidone palmitate and its effect on the recurrence of schizophrenics. Pract Pharm Clin Remedies. 2019;22(03):282–285.
   Google Scholar
• Barfar E, Sharifi V, Amini H. Cost-effectiveness analysis of an aftercare service vs treatment-as-usual for patients with severe mental disorders. J Ment Health Policy Econ. 2017;20(3):101.
   Web of Science ®Google Scholar
• Liu S. Impact of health education on rehabilitation of schizophrenic patients. Health Care Guide. 2019;17:102.
   Google Scholar
• Lai H, Li S, Mao C. Investigation on the therapeutic compliance of acute schizophrenic patients with psychotic symptoms and the emotional expression of their family members. West Chin Med J. 2016;31(5):936–939.
   Google Scholar
• Jiang L. Factors affecting the compliance of patients with mental illness during the rehabilitation period and nursing countermeasures medical. J Chin People’s Health. 2010;22(2):167–172.
   Google Scholar
• Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150(4):327–333. doi:10.1093/oxfordjournals.aje.a010011
   PubMed Web of Science ®Google Scholar